Eyevensys is Drug Discovery in France that focus on degenerative retinal diseases business. Founded in 2008. They cover business area such as developer, therapeutic protein, ophthalmology, both short and long-term therapeutic outcome, chronic non-infectious uveitis, degenerative retinal disease, retinal vascular disease, macular oedema, compliance, ocular bioavailability, tolerability, physician, major ophthalmic condition.
2008
( 16 years old in 2024 )
Degenerative Retinal Diseases
-
Biopark
11 Rue Watt Bat B
75013 Paris
France
Private
developertherapeutic proteinophthalmologyboth short and long-term therapeutic outcomechronic non-infectious uveitisdegenerative retinal diseaseretinal vascular diseasemacular oedemacomplianceocular bioavailabilitytolerabilityphysicianmajor ophthalmic condition
* We use standard office opening hours in near Eyevensys's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eyevensys is Drug Discovery business from France that founded in 2008 (16 years old in 2024), Eyevensys business is focusing on Degenerative Retinal Diseases.
Eyevensys headquarter office and corporate office address is located in Biopark 11 Rue Watt Bat B 75013 Paris France.
Eyevensys was founded in France.
In 2024, Eyevensys is currently focus on degenerative retinal diseases sector.
Above is snippet of Google Trends for "degenerative retinal diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eyevensys, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
